|
1
|
Nowell SA, Ahn J and Ambrosone CB:
Gene-nutrient interactions in cancer etiology. Nutr Rev.
62:427–438. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Song M, Lee KM and Kang D: Breast cancer
prevention based on gene-environment interaction. Mol Carcinog.
50:280–290. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chia KS: Gene-environment interactions in
breast cancer. Novartis Found Symp. 293:143–150; discussion
150–155, 181–183. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rubin BS: Bisphenol A: An endocrine
disruptor with widespread exposure and multiple effects. J Steroid
Biochem Mol Biol. 127:27–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Belpomme D, Irigaray P, Hardell L, Clapp
R, Montagnier L, Epstein S and Sasco AJ: The multitude and
diversity of environmental carcinogens. Environ Res. 105:414–429.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schell LM, Burnitz KK and Lathrop PW:
Pollution and human biology. Ann Hum Biol. 37:347–366. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Majkova Z, Toborek M and Hennig B: The
role of caveolae in endothelial cell dysfunction with a focus on
nutrition and environmental toxicants. J Cell Mol Med.
14:2359–2370. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rybicki BA, Nock NL, Savera AT, Tang D and
Rundle A: Polycyclic aromatic hydrocarbon-DNA adduct formation in
prostate carcinogenesis. Cancer Lett. 239:157–167. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Singhal R, Shankar K, Badger TM and Ronis
MJ: Estrogenic status modulates aryl hydrocarbon receptor-mediated
hepatic gene expression and carcinogenicity. Carcinogenesis.
29:227–236. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mehta RG, Naithani R, Huma L, Hawthorne M,
Moriarty RM, McCormick DL, Steele VE and Kopelovich L: Efficacy of
chemopreventive agents in mouse mammary gland organ culture (MMOC)
model: A comprehensive review. Curr Med Chem. 15:2785–2825. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Currier N, Solomon SE, Demicco EG, Chang
DL, Farago M, Ying H, Dominguez I, Sonenshein GE, Cardiff RD, Xiao
ZX, et al: Oncogenic signaling pathways activated in DMBA-induced
mouse mammary tumors. Toxicol Pathol. 33:726–737. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nebert DW, Petersen DD and Fornace AJ Jr:
Cellular responses to oxidative stress: The [Ah] gene battery as a
paradigm. Environ Health Perspect. 88:13–25. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rundle A, Tang D, Hibshoosh H, Estabrook
A, Schnabel F, Cao W, Grumet S and Perera FP: The relationship
between genetic damage from polycyclic aromatic hydrocarbons in
breast tissue and breast cancer. Carcinogenesis. 21:1281–1289.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Papaconstantinou AD, Shanmugam I, Shan L,
Schroeder IS, Qiu C, Yu M and Snyderwine EG: Gene expression
profiling in the mammary gland of rats treated with
7,12-dimethylbenz[a]anthracene. Int J Cancer. 118:17–24. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu E, Thor A, He M, Barcos M, Ljung BM
and Benz C: The HER2 (c-erbB-2) oncogene is frequently amplified in
in situ carcinomas of the breast. Oncogene. 7:1027–1032.
1992.PubMed/NCBI
|
|
16
|
Jardines L, Weiss M and Fowble B: Greene
Mneu(c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR)
in breast cancer. Pathobiology. 61:268–282. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hynes NE and Stern DF: The biology of
erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta.
1198:165–184. 1994.PubMed/NCBI
|
|
18
|
Citri A and Yarden Y: EGF-ERBB signalling:
Towards the systems level. Nat Rev Mol Cell Biol. 7:505–516. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guy CT, Webster MA, Schaller M, Parsons
TJ, Cardiff RD and Muller WJ: Expression of the neu protooncogene
in the mammary epithelium of transgenic mice induces metastatic
disease. Proc Natl Acad Sci USA. 89:10578–10582. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bouchard L, Lamarre L, Tremblay PJ and
Jolicoeur P: Stochastic appearance of mammary tumors in transgenic
mice carrying the MMTV/c-neu oncogene. Cell. 57:931–936. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marcotte R and Muller WJ: Signal
transduction in transgenic mouse models of human breast
cancer-implications for human breast cancer. J Mammary Gland Biol
Neoplasia. 13:323–335. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hutchinson JN and Muller WJ: Transgenic
mouse models of human breast cancer. Oncogene. 19:6130–6137. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang X, Yang S, McKimmey C, Liu B,
Edgerton SM, Bales W, Archer LT and Thor AD: Genistein induces
enhanced growth promotion in ER-positive/erbB-2-overexpressing
breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation.
Carcinogenesis. 31:695–702. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang X, Edgerton SM, Kosanke SD, Mason TL,
Alvarez KM, Liu N, Chatterton RT, Liu B, Wang Q, Kim A, et al:
Hormonal and dietary modulation of mammary carcinogenesis in mouse
mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res.
63:2425–2433. 2003.PubMed/NCBI
|
|
25
|
Warin R, Chambers WH, Potter DM and Singh
SV: Prevention of mammary carcinogenesis in MMTV-neu mice by
cruciferous vegetable constituent benzyl isothiocyanate. Cancer
Res. 69:9473–9480. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shen K and Novak RF: DDT stimulates
c-erbB2, c-met, and STATS tyrosine phosphorylation, Grb2-Sos
association, MAPK phosphorylation, and proliferation of human
breast epithelial cells. Biochem Biophys Res Commun. 231:17–21.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shan L, Yu M and Snyderwine EG: Global
gene expression profiling of chemically induced rat mammary gland
carcinomas and adenomas. Toxicol Pathol. 33:768–775. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shan L, He M, Yu M, Qiu C, Lee NH, Liu ET
and Snyderwine EG: cDNA microarray profiling of rat mammary gland
carcinomas induced by
2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and
7,12-dimethylbenz[a]anthracene. Carcinogenesis. 23:1561–1568. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim YM, Ma Z, Lee S, Lee J, Li S and Yang
X: Trisomy chromosome 5 is a recurrent cytogenetic lesion in
mammary tumors from parous MMTV-erbB-2 transgenic mice. Oncol Lett.
2:1077–1081. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
de Oliveira Andrade F, Fontelles CC, Rosim
MP, de Oliveira TF, de Melo Loureiro AP, Mancini-Filho J, Rogero
MM, Moreno FS, de Assis S, Barbisan LF, et al: Exposure to
lard-based high-fat diet during fetal and lactation periods
modifies breast cancer susceptibility in adulthood in rats. J Nutr
Biochem. 25:613–622. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qin LQ, Xu JY, Tezuka H, Wang PY and Hoshi
K: Commercial soy milk enhances the development of
7,12-dimethylbenz(a) anthracene-induced mammary tumors in rats. In
Vivo. 21:667–671. 2007.PubMed/NCBI
|
|
33
|
Qi C, Lan H, Ye J, Li W, Wei P, Yang Y,
Guo S, Lan T, Li J, Zhang Q, et al: Slit2 promotes tumor growth and
invasion in chemically induced skin carcinogenesis. Lab Invest.
94:766–776. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Muller WJ, Sinn E, Pattengale PK, Wallace
R and Leder P: Single-step induction of mammary adenocarcinoma in
transgenic mice bearing the activated c-neu oncogene. Cell.
54:105–115. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mohibi S, Mirza S, Band H and Band V:
Mouse models of estrogen receptor-positive breast cancer. J
Carcinog. 10:352011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cool M, Depault F and Jolicoeur P: Fine
allelotyping of Erbb2-induced mammary tumors in mice reveals
multiple discontinuous candidate regions of tumor-suppressor loci.
Genes Chromosomes Cancer. 45:191–202. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu S, Liu W, Jakubczak JL, Erexson GL,
Tindall KR, Chan R, Muller WJ, Adhya S, Garges S and Merlino G:
Genetic instability favoring transversions associated with
ErbB2-induced mammary tumorigenesis. Proc Natl Acad Sci USA.
99:3770–3775. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Daniel FB and Joyce NJ: DNA adduct
formation by 7, 12-dimethylbenz[a]anthracene and its
noncarcinogenic 2-fluoro analogue in female Sprague-Dawley rats. J
Natl Cancer Inst. 70:111–118. 1983.PubMed/NCBI
|
|
39
|
Russo IH and Russo J: Mammary gland
neoplasia in long-term rodent studies. Environ Health Perspect.
104:938–967. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Umekita Y, Souda M, Hatanaka K, Hamada T,
Yoshioka T, Kawaguchi H and Tanimoto A: Gene expression profile of
terminal end buds in rat mammary glands exposed to
diethylstilbestrol in neonatal period. Toxicol Lett. 205:15–25.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hsu PY, Deatherage DE, Rodriguez BA,
Liyanarachchi S, Weng YI, Zuo T, Liu J, Cheng AS and Huang TH:
Xenoestrogen-induced epigenetic repression of microRNA-9-3 in
breast epithelial cells. Cancer Res. 69:5936–5945. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lamartiniere CA, Jenkins S, Betancourt AM,
Wang J and Russo J: Exposure to the endocrine disruptor bisphenol a
alters susceptibility for mammary cancer. Horm Mol Biol Clin
Investig. 5:45–52. 2011.PubMed/NCBI
|
|
43
|
Wogan GN, Hecht SS, Felton JS, Conney AH
and Loeb LA: Environmental and chemical carcinogenesis. Semin
Cancer Biol. 14:473–486. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Medina D: Chemical carcinogenesis of rat
and mouse mammary glands. Breast Dis. 28:63–68. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Plante I, Stewart MK, Barr K, Allan AL and
Laird DW: Cx43 suppresses mammary tumor metastasis to the lung in a
Cx43 mutant mouse model of human disease. Oncogene. 30:1681–1692.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Russo J and Russo IH: Influence of
differentiation and cell kinetics on the susceptibility of the rat
mammary gland to carcinogenesis. Cancer Res. 40:2677–2687.
1980.PubMed/NCBI
|
|
47
|
Markey CM, Luque EH, Munoz De Toro M,
Sonnenschein C and Soto AM: In utero exposure to bisphenol A alters
the development and tissue organization of the mouse mammary gland.
Biol Reprod. 65:1215–1223. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Coffey RJ Jr, Meise KS, Matsui Y, Hogan
BL, Dempsey PJ and Halter SA: Acceleration of mammary neoplasia in
transforming growth factor alpha transgenic mice by
7,12-dimethylbenzanthracene. Cancer Res. 54:1678–1683.
1994.PubMed/NCBI
|
